November’s Small-Cap Treasures: 3 Stocks Poised for Growth
Three promising small-cap stocks, poised for growth in healthcare, cybersecurity, and renewable energy, offer compelling investment opportunities for November.
Cognition Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
Ongoing Patient Dosing in SHIMMER Study for DLB and SHINE Study for Alzheimer’s DiseasePositive Preliminary Data for Dry AMD Program Presented at ARVO...
Cognition Therapeutics Presents New Proteomic Data on Effect of CT1812 Treatment on Normalization of Disrupted Alzheimer’s Disease Processes
Presented at Alzheimer’s Association International Conference August 4, 2022...
Cognition Therapeutics Presenting New Analyses from Ongoing Clinical Trial of CT1812 in Mild-to-Moderate Alzheimer’s Disease
- Analyses Demonstrate CT1812 Impact on Alzheimer’s Disease Processes - NEW YORK, July 19, 2022 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc....